Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02617797
Other study ID # U1111-1162-0945
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 2015
Est. completion date June 2025

Study information

Verified date June 2023
Source Centro de Atenção ao Assoalho Pélvico
Contact Patricia V Lordelo, Phd
Phone +5571988592400
Email pvslordelo@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Urinary stress incontinence ( SUI ) is defined as an involuntary loss of urinary Complaint no effort According to the Consensus of the International Continence Society (Society Continence International - ICS) . SUI Prevalence of adult female Population and 25 % to 30 %.However, despite the high prevalence, many women who have symptoms of SUI or not seek treatment remain without resolution of symptoms.Then there is the possibility of using non-invasive radiofrequency and non-ablation in external urethral meatus in order to stimulate collagen production, as one of the pathophysiological mechanisms of stress urinary incontinence is the collagen deficit in the urethral wall. It is a randomized clinical trial and the group experimental will utilize radiofrequency and kinesiotheraphy ( clinical and in home) and the group control utilize turn off- radiofrequency and kinesiotherapy (clinical and in home). The protocol f the kinesiotherapy is the same both the group, and the protocol radiofrequency the group experimental will 5 sessions (one per week) with temperature 38ºC during 2 minutes. The group control will 5 sessions (one per week) but the radiofrequency will off but glycerin is heated, for masking for the patient, during 2 min. The result of the treatment is assessed by pad test 1 hour and have others outcomes ( quality of life- Sf-26 ans King Health- and sexual function- FSFI questionaire)


Recruitment information / eligibility

Status Recruiting
Enrollment 42
Est. completion date June 2025
Est. primary completion date June 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 59 Years
Eligibility Inclusion Criteria: - 21 Women with age between 18-59 years old, - women with diagnosis of urinary incontinence and have a Pelvic floor muscle contractility was assessed by digital palpation using the validated Modified Oxford Scale (MOS) greater than or equal to three Exclusion Criteria: - Patients with cognitive deficits or psychiatric illness; - suffering from chronic degenerative neurological diseases; which have greater than 50 ml post-voiding residue ; - sensory deficit in the genital region; - people with pacemakers and implantable cardioverter-defibrillator and pregnant women will be excluded from the study

Study Design


Intervention

Device:
Radiofrequency
The radiofrequency is a noninvasive technique that will be applied to the external urethral meatus region.It will use a digital thermometer with infrared to mention the temperature should reach 39 ° C and maintain this temperature for 2 minutes.It will use a digital thermometer with infrared to mention the temperature should reach 39 ° C and maintain this temperature for 2 minutes
Radiofrequency OFF
Will be used to put off radio frequency will be heated glycerin to occur masking for the patient.

Locations

Country Name City State
Brazil Centro de Atenção ao Assoalho Pelvico Salvador Ba

Sponsors (1)

Lead Sponsor Collaborator
Centro de Atenção ao Assoalho Pélvico

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Urinary loss modification The pad test will be held at the beginning of treatment and one week, one month, two month, three month and six month after the last session of radio frequency. The pad test it quantifies in grams urinary loss through the absorbent weighing. one week, one month, two month , three month and six month
Secondary specific Quality of life The quality of life will be assessed by one for specific urinary symptoms - Health King , measure with unit of the scale one week
Secondary Sexual Function Will be evaluated before and after radio frequency sexual function of women, through questionary FSFI in which there is a switching station which evaluates the presence of sexual dysfunction, and there is specific scores for the domains of pain, desire, lubrication, arousal, orgasm, and satisfaction. one week
Secondary overall quality of life Will be evaluated before and after radio frequency the overall quality of life - SF-36 - questionaire. one week
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02867748 - TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings N/A
Active, not recruiting NCT02538991 - TVT Versus Bulkamid®-Injections in Treatment of Stress Urinary Incontinence N/A
Completed NCT02480231 - Mid-Urethral Sling Tensioning Trial N/A
Terminated NCT02591381 - Transcorporal Versus Standard Artificial Urinary Sphincter Placement N/A
Completed NCT00984958 - Bulkamid Treatment of Stress Incontinence in Women With Urinary Stress Incontinence and Not Suitable to TVT-procedure N/A
Completed NCT00190567 - Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence Phase 2
Completed NCT02423486 - The Comparison of Efficacy Between Electromagnetic Stimulation Therapy and Electromagnetic Stimulation Therapy With Extracorporeal Biofeedback N/A
Completed NCT01754558 - One Year Outcome Using the Ajust System for Treatment of Urinary Stress Incontinence N/A
Recruiting NCT00136071 - Transvaginal Tension Free Vaginal Tape-Obturator (TVT-O) Versus Transobturator Tape-Mentor (TOT) in the Management of Urodynamic Stress Urinary Incontinence N/A
Completed NCT00190619 - Efficacy and Safety of Duloxetine Phase 3
Completed NCT04288648 - Pelvic Floor Contraction in Different Positions Among Women With and Without Stress Urinary Incontinence
Active, not recruiting NCT05182632 - Tele-rehabilitation Group Program for Urinary Incontinence in Older Women N/A
Completed NCT03672461 - A Group-Based Therapeutic Yoga Intervention for Urinary Incontinence in Ambulatory Older Women N/A
Completed NCT02407145 - Safety and Efficacy of PVDF (DynaMesh®-SIS Soft) Retropubic Midurethral Slings in Stress Urinary Incontinence in Women
Completed NCT01784172 - Efficacy and Safety Study of Electroacupuncture for Simple Female Stress Urinary incontinence-a Multicenter Trial Phase 2
Recruiting NCT02935803 - A Study on the Anti-incontinent Effectiveness of the mTVM Method in POPQ Stage II-III Patients N/A
Active, not recruiting NCT02039830 - Group Versus Individual Physiotherapy for Urinary Incontinence in Aging Women N/A
Recruiting NCT04817839 - Optimal Duration of Post-Operative Activity Restriction After Midurethral Sling Procedures N/A
Completed NCT03439527 - Multisystem Cell Therapy for Improvement of Urinary Continence Phase 1
Completed NCT01392651 - Tension-free-vaginal-tape-obturator (TVTO) Versus Tension-free-vaginal-tape-Secur (TVTS) for Treatment of SUI N/A